Stem Cells Industry Research Report 2024
Summary
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
According to APO Research, The global Stem Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Stem Cells include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cells.
The Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
According to APO Research, The global Stem Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Stem Cells include Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi-post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen and Takeda (TiGenix), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cells.
The Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Osiris Therapeutics
- NuVasive
- Chiesi Pharmaceuticals
- Medi-post
- JCR Pharmaceutical
- MolMed
- Pharmicell
- Anterogen
- Takeda (TiGenix)
- CBR
- ViaCord
- Esperite
- LifeCell
- CCBC
- VCANBIO
- BOYA LIFE
- Beike Biotechnology
- International Medical
- Stem Cell Storage
- Stem Cell Pharmaceutical and Treatment
- Diseases of the Central Nervous System
- Cardiovascular Disease
- Diabetes
- Cancer
- Genetic Diseases
- Autoimmune Disease
- Bone and Cartilage Repair
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Stem Cells companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Stem Cells by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Stem Cell Storage
2.2.3 Stem Cell Pharmaceutical and Treatment
2.3 Stem Cells by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Diseases of the Central Nervous System
2.3.3 Cardiovascular Disease
2.3.4 Diabetes
2.3.5 Cancer
2.3.6 Genetic Diseases
2.3.7 Autoimmune Disease
2.3.8 Bone and Cartilage Repair
2.3.9 Other
2.4 Assumptions and Limitations
3 STEM CELLS BREAKDOWN DATA BY TYPE
3.1 Global Stem Cells Historic Market Size by Type (2019-2024)
3.2 Global Stem Cells Forecasted Market Size by Type (2025-2030)
4 STEM CELLS BREAKDOWN DATA BY APPLICATION
4.1 Global Stem Cells Historic Market Size by Application (2019-2024)
4.2 Global Stem Cells Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Stem Cells Market Perspective (2019-2030)
5.2 Global Stem Cells Growth Trends by Region
5.2.1 Global Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Stem Cells Historic Market Size by Region (2019-2024)
5.2.3 Stem Cells Forecasted Market Size by Region (2025-2030)
5.3 Stem Cells Market Dynamics
5.3.1 Stem Cells Industry Trends
5.3.2 Stem Cells Market Drivers
5.3.3 Stem Cells Market Challenges
5.3.4 Stem Cells Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Stem Cells Players by Revenue
6.1.1 Global Top Stem Cells Players by Revenue (2019-2024)
6.1.2 Global Stem Cells Revenue Market Share by Players (2019-2024)
6.2 Global Stem Cells Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Stem Cells Head office and Area Served
6.4 Global Stem Cells Players, Product Type & Application
6.5 Global Stem Cells Players, Date of Enter into This Industry
6.6 Global Stem Cells Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Stem Cells Market Size (2019-2030)
7.2 North America Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Stem Cells Market Size by Country (2019-2024)
7.4 North America Stem Cells Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Stem Cells Market Size (2019-2030)
8.2 Europe Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Stem Cells Market Size by Country (2019-2024)
8.4 Europe Stem Cells Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Stem Cells Market Size (2019-2030)
9.2 Asia-Pacific Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Stem Cells Market Size by Country (2019-2024)
9.4 Asia-Pacific Stem Cells Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Stem Cells Market Size (2019-2030)
10.2 Latin America Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Stem Cells Market Size by Country (2019-2024)
10.4 Latin America Stem Cells Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Stem Cells Market Size (2019-2030)
11.2 Middle East & Africa Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Stem Cells Market Size by Country (2019-2024)
11.4 Middle East & Africa Stem Cells Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Osiris Therapeutics
12.1.1 Osiris Therapeutics Company Information
12.1.2 Osiris Therapeutics Business Overview
12.1.3 Osiris Therapeutics Revenue in Stem Cells Business (2019-2024)
12.1.4 Osiris Therapeutics Stem Cells Product Portfolio
12.1.5 Osiris Therapeutics Recent Developments
12.2 NuVasive
12.2.1 NuVasive Company Information
12.2.2 NuVasive Business Overview
12.2.3 NuVasive Revenue in Stem Cells Business (2019-2024)
12.2.4 NuVasive Stem Cells Product Portfolio
12.2.5 NuVasive Recent Developments
12.3 Chiesi Pharmaceuticals
12.3.1 Chiesi Pharmaceuticals Company Information
12.3.2 Chiesi Pharmaceuticals Business Overview
12.3.3 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2019-2024)
12.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
12.3.5 Chiesi Pharmaceuticals Recent Developments
12.4 Medi-post
12.4.1 Medi-post Company Information
12.4.2 Medi-post Business Overview
12.4.3 Medi-post Revenue in Stem Cells Business (2019-2024)
12.4.4 Medi-post Stem Cells Product Portfolio
12.4.5 Medi-post Recent Developments
12.5 JCR Pharmaceutical
12.5.1 JCR Pharmaceutical Company Information
12.5.2 JCR Pharmaceutical Business Overview
12.5.3 JCR Pharmaceutical Revenue in Stem Cells Business (2019-2024)
12.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
12.5.5 JCR Pharmaceutical Recent Developments
12.6 MolMed
12.6.1 MolMed Company Information
12.6.2 MolMed Business Overview
12.6.3 MolMed Revenue in Stem Cells Business (2019-2024)
12.6.4 MolMed Stem Cells Product Portfolio
12.6.5 MolMed Recent Developments
12.7 Pharmicell
12.7.1 Pharmicell Company Information
12.7.2 Pharmicell Business Overview
12.7.3 Pharmicell Revenue in Stem Cells Business (2019-2024)
12.7.4 Pharmicell Stem Cells Product Portfolio
12.7.5 Pharmicell Recent Developments
12.8 Anterogen
12.8.1 Anterogen Company Information
12.8.2 Anterogen Business Overview
12.8.3 Anterogen Revenue in Stem Cells Business (2019-2024)
12.8.4 Anterogen Stem Cells Product Portfolio
12.8.5 Anterogen Recent Developments
12.9 Takeda (TiGenix)
12.9.1 Takeda (TiGenix) Company Information
12.9.2 Takeda (TiGenix) Business Overview
12.9.3 Takeda (TiGenix) Revenue in Stem Cells Business (2019-2024)
12.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
12.9.5 Takeda (TiGenix) Recent Developments
12.10 CBR
12.10.1 CBR Company Information
12.10.2 CBR Business Overview
12.10.3 CBR Revenue in Stem Cells Business (2019-2024)
12.10.4 CBR Stem Cells Product Portfolio
12.10.5 CBR Recent Developments
12.11 ViaCord
12.11.1 ViaCord Company Information
12.11.2 ViaCord Business Overview
12.11.3 ViaCord Revenue in Stem Cells Business (2019-2024)
12.11.4 ViaCord Stem Cells Product Portfolio
12.11.5 ViaCord Recent Developments
12.12 Esperite
12.12.1 Esperite Company Information
12.12.2 Esperite Business Overview
12.12.3 Esperite Revenue in Stem Cells Business (2019-2024)
12.12.4 Esperite Stem Cells Product Portfolio
12.12.5 Esperite Recent Developments
12.13 LifeCell
12.13.1 LifeCell Company Information
12.13.2 LifeCell Business Overview
12.13.3 LifeCell Revenue in Stem Cells Business (2019-2024)
12.13.4 LifeCell Stem Cells Product Portfolio
12.13.5 LifeCell Recent Developments
12.14 CCBC
12.14.1 CCBC Company Information
12.14.2 CCBC Business Overview
12.14.3 CCBC Revenue in Stem Cells Business (2019-2024)
12.14.4 CCBC Stem Cells Product Portfolio
12.14.5 CCBC Recent Developments
12.15 VCANBIO
12.15.1 VCANBIO Company Information
12.15.2 VCANBIO Business Overview
12.15.3 VCANBIO Revenue in Stem Cells Business (2019-2024)
12.15.4 VCANBIO Stem Cells Product Portfolio
12.15.5 VCANBIO Recent Developments
12.16 BOYA LIFE
12.16.1 BOYA LIFE Company Information
12.16.2 BOYA LIFE Business Overview
12.16.3 BOYA LIFE Revenue in Stem Cells Business (2019-2024)
12.16.4 BOYA LIFE Stem Cells Product Portfolio
12.16.5 BOYA LIFE Recent Developments
12.17 Beike Biotechnology
12.17.1 Beike Biotechnology Company Information
12.17.2 Beike Biotechnology Business Overview
12.17.3 Beike Biotechnology Revenue in Stem Cells Business (2019-2024)
12.17.4 Beike Biotechnology Stem Cells Product Portfolio
12.17.5 Beike Biotechnology Recent Developments
12.18 International Medical
12.18.1 International Medical Company Information
12.18.2 International Medical Business Overview
12.18.3 International Medical Revenue in Stem Cells Business (2019-2024)
12.18.4 International Medical Stem Cells Product Portfolio
12.18.5 International Medical Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Stem Cells by Type
2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
2.2.2 Stem Cell Storage
2.2.3 Stem Cell Pharmaceutical and Treatment
2.3 Stem Cells by Application
2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
2.3.2 Diseases of the Central Nervous System
2.3.3 Cardiovascular Disease
2.3.4 Diabetes
2.3.5 Cancer
2.3.6 Genetic Diseases
2.3.7 Autoimmune Disease
2.3.8 Bone and Cartilage Repair
2.3.9 Other
2.4 Assumptions and Limitations
3 STEM CELLS BREAKDOWN DATA BY TYPE
3.1 Global Stem Cells Historic Market Size by Type (2019-2024)
3.2 Global Stem Cells Forecasted Market Size by Type (2025-2030)
4 STEM CELLS BREAKDOWN DATA BY APPLICATION
4.1 Global Stem Cells Historic Market Size by Application (2019-2024)
4.2 Global Stem Cells Forecasted Market Size by Application (2019-2024)
5 GLOBAL GROWTH TRENDS
5.1 Global Stem Cells Market Perspective (2019-2030)
5.2 Global Stem Cells Growth Trends by Region
5.2.1 Global Stem Cells Market Size by Region: 2019 VS 2023 VS 2030
5.2.2 Stem Cells Historic Market Size by Region (2019-2024)
5.2.3 Stem Cells Forecasted Market Size by Region (2025-2030)
5.3 Stem Cells Market Dynamics
5.3.1 Stem Cells Industry Trends
5.3.2 Stem Cells Market Drivers
5.3.3 Stem Cells Market Challenges
5.3.4 Stem Cells Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Stem Cells Players by Revenue
6.1.1 Global Top Stem Cells Players by Revenue (2019-2024)
6.1.2 Global Stem Cells Revenue Market Share by Players (2019-2024)
6.2 Global Stem Cells Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Stem Cells Head office and Area Served
6.4 Global Stem Cells Players, Product Type & Application
6.5 Global Stem Cells Players, Date of Enter into This Industry
6.6 Global Stem Cells Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Stem Cells Market Size (2019-2030)
7.2 North America Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Stem Cells Market Size by Country (2019-2024)
7.4 North America Stem Cells Market Size by Country (2025-2030)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Stem Cells Market Size (2019-2030)
8.2 Europe Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Stem Cells Market Size by Country (2019-2024)
8.4 Europe Stem Cells Market Size by Country (2025-2030)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Russia
8.10 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Stem Cells Market Size (2019-2030)
9.2 Asia-Pacific Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Stem Cells Market Size by Country (2019-2024)
9.4 Asia-Pacific Stem Cells Market Size by Country (2025-2030)
9.5 China
9.6 Japan
9.7 South Korea
9.8 Southeast Asia
9.9 India
9.10 Australia
10 LATIN AMERICA
10.1 Latin America Stem Cells Market Size (2019-2030)
10.2 Latin America Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Stem Cells Market Size by Country (2019-2024)
10.4 Latin America Stem Cells Market Size by Country (2025-2030)
10.5 Mexico
10.6 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Stem Cells Market Size (2019-2030)
11.2 Middle East & Africa Stem Cells Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Stem Cells Market Size by Country (2019-2024)
11.4 Middle East & Africa Stem Cells Market Size by Country (2025-2030)
11.5 Turkey
11.6 Saudi Arabia
11.7 UAE
12 PLAYERS PROFILED
12.1 Osiris Therapeutics
12.1.1 Osiris Therapeutics Company Information
12.1.2 Osiris Therapeutics Business Overview
12.1.3 Osiris Therapeutics Revenue in Stem Cells Business (2019-2024)
12.1.4 Osiris Therapeutics Stem Cells Product Portfolio
12.1.5 Osiris Therapeutics Recent Developments
12.2 NuVasive
12.2.1 NuVasive Company Information
12.2.2 NuVasive Business Overview
12.2.3 NuVasive Revenue in Stem Cells Business (2019-2024)
12.2.4 NuVasive Stem Cells Product Portfolio
12.2.5 NuVasive Recent Developments
12.3 Chiesi Pharmaceuticals
12.3.1 Chiesi Pharmaceuticals Company Information
12.3.2 Chiesi Pharmaceuticals Business Overview
12.3.3 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2019-2024)
12.3.4 Chiesi Pharmaceuticals Stem Cells Product Portfolio
12.3.5 Chiesi Pharmaceuticals Recent Developments
12.4 Medi-post
12.4.1 Medi-post Company Information
12.4.2 Medi-post Business Overview
12.4.3 Medi-post Revenue in Stem Cells Business (2019-2024)
12.4.4 Medi-post Stem Cells Product Portfolio
12.4.5 Medi-post Recent Developments
12.5 JCR Pharmaceutical
12.5.1 JCR Pharmaceutical Company Information
12.5.2 JCR Pharmaceutical Business Overview
12.5.3 JCR Pharmaceutical Revenue in Stem Cells Business (2019-2024)
12.5.4 JCR Pharmaceutical Stem Cells Product Portfolio
12.5.5 JCR Pharmaceutical Recent Developments
12.6 MolMed
12.6.1 MolMed Company Information
12.6.2 MolMed Business Overview
12.6.3 MolMed Revenue in Stem Cells Business (2019-2024)
12.6.4 MolMed Stem Cells Product Portfolio
12.6.5 MolMed Recent Developments
12.7 Pharmicell
12.7.1 Pharmicell Company Information
12.7.2 Pharmicell Business Overview
12.7.3 Pharmicell Revenue in Stem Cells Business (2019-2024)
12.7.4 Pharmicell Stem Cells Product Portfolio
12.7.5 Pharmicell Recent Developments
12.8 Anterogen
12.8.1 Anterogen Company Information
12.8.2 Anterogen Business Overview
12.8.3 Anterogen Revenue in Stem Cells Business (2019-2024)
12.8.4 Anterogen Stem Cells Product Portfolio
12.8.5 Anterogen Recent Developments
12.9 Takeda (TiGenix)
12.9.1 Takeda (TiGenix) Company Information
12.9.2 Takeda (TiGenix) Business Overview
12.9.3 Takeda (TiGenix) Revenue in Stem Cells Business (2019-2024)
12.9.4 Takeda (TiGenix) Stem Cells Product Portfolio
12.9.5 Takeda (TiGenix) Recent Developments
12.10 CBR
12.10.1 CBR Company Information
12.10.2 CBR Business Overview
12.10.3 CBR Revenue in Stem Cells Business (2019-2024)
12.10.4 CBR Stem Cells Product Portfolio
12.10.5 CBR Recent Developments
12.11 ViaCord
12.11.1 ViaCord Company Information
12.11.2 ViaCord Business Overview
12.11.3 ViaCord Revenue in Stem Cells Business (2019-2024)
12.11.4 ViaCord Stem Cells Product Portfolio
12.11.5 ViaCord Recent Developments
12.12 Esperite
12.12.1 Esperite Company Information
12.12.2 Esperite Business Overview
12.12.3 Esperite Revenue in Stem Cells Business (2019-2024)
12.12.4 Esperite Stem Cells Product Portfolio
12.12.5 Esperite Recent Developments
12.13 LifeCell
12.13.1 LifeCell Company Information
12.13.2 LifeCell Business Overview
12.13.3 LifeCell Revenue in Stem Cells Business (2019-2024)
12.13.4 LifeCell Stem Cells Product Portfolio
12.13.5 LifeCell Recent Developments
12.14 CCBC
12.14.1 CCBC Company Information
12.14.2 CCBC Business Overview
12.14.3 CCBC Revenue in Stem Cells Business (2019-2024)
12.14.4 CCBC Stem Cells Product Portfolio
12.14.5 CCBC Recent Developments
12.15 VCANBIO
12.15.1 VCANBIO Company Information
12.15.2 VCANBIO Business Overview
12.15.3 VCANBIO Revenue in Stem Cells Business (2019-2024)
12.15.4 VCANBIO Stem Cells Product Portfolio
12.15.5 VCANBIO Recent Developments
12.16 BOYA LIFE
12.16.1 BOYA LIFE Company Information
12.16.2 BOYA LIFE Business Overview
12.16.3 BOYA LIFE Revenue in Stem Cells Business (2019-2024)
12.16.4 BOYA LIFE Stem Cells Product Portfolio
12.16.5 BOYA LIFE Recent Developments
12.17 Beike Biotechnology
12.17.1 Beike Biotechnology Company Information
12.17.2 Beike Biotechnology Business Overview
12.17.3 Beike Biotechnology Revenue in Stem Cells Business (2019-2024)
12.17.4 Beike Biotechnology Stem Cells Product Portfolio
12.17.5 Beike Biotechnology Recent Developments
12.18 International Medical
12.18.1 International Medical Company Information
12.18.2 International Medical Business Overview
12.18.3 International Medical Revenue in Stem Cells Business (2019-2024)
12.18.4 International Medical Stem Cells Product Portfolio
12.18.5 International Medical Recent Developments
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Stem Cells Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Stem Cells Revenue Market Share by Type (2018-2023)
Table 7. Global Stem Cells Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Stem Cells Revenue Market Share by Type (2024-2029)
Table 9. Global Stem Cells Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Stem Cells Revenue Market Share by Application (2018-2023)
Table 11. Global Stem Cells Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Stem Cells Revenue Market Share by Application (2024-2029)
Table 13. Global Stem Cells Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Stem Cells Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Stem Cells Market Share by Region (2018-2023)
Table 16. Global Stem Cells Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Stem Cells Market Share by Region (2024-2029)
Table 18. Stem Cells Market Trends
Table 19. Stem Cells Market Drivers
Table 20. Stem Cells Market Challenges
Table 21. Stem Cells Market Restraints
Table 22. Global Top Stem Cells Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Stem Cells Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Stem Cells Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Stem Cells, Headquarters and Area Served
Table 26. Global Stem Cells Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Stem Cells by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 45. Osiris Therapeutics Company Detail
Table 46. Osiris Therapeutics Business Overview
Table 47. Osiris Therapeutics Stem Cells Product
Table 48. Osiris Therapeutics Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 49. Osiris Therapeutics Recent Development
Table 50. NuVasive Company Detail
Table 51. NuVasive Business Overview
Table 52. NuVasive Stem Cells Product
Table 53. NuVasive Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 54. NuVasive Recent Development
Table 55. Chiesi Pharmaceuticals Company Detail
Table 56. Chiesi Pharmaceuticals Business Overview
Table 57. Chiesi Pharmaceuticals Stem Cells Product
Table 58. Chiesi Pharmaceuticals Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 59. Chiesi Pharmaceuticals Recent Development
Table 60. Medi-post Company Detail
Table 61. Medi-post Business Overview
Table 62. Medi-post Stem Cells Product
Table 63. Medi-post Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 64. Medi-post Recent Development
Table 65. JCR Pharmaceutical Company Detail
Table 66. JCR Pharmaceutical Business Overview
Table 67. JCR Pharmaceutical Stem Cells Product
Table 68. JCR Pharmaceutical Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 69. JCR Pharmaceutical Recent Development
Table 70. MolMed Company Detail
Table 71. MolMed Business Overview
Table 72. MolMed Stem Cells Product
Table 73. MolMed Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 74. MolMed Recent Development
Table 75. Pharmicell Company Detail
Table 76. Pharmicell Business Overview
Table 77. Pharmicell Stem Cells Product
Table 78. Pharmicell Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 79. Pharmicell Recent Development
Table 80. Anterogen Company Detail
Table 81. Anterogen Business Overview
Table 82. Anterogen Stem Cells Product
Table 83. Anterogen Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 84. Anterogen Recent Development
Table 85. Takeda (TiGenix) Company Detail
Table 86. Takeda (TiGenix) Business Overview
Table 87. Takeda (TiGenix) Stem Cells Product
Table 88. Takeda (TiGenix) Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 89. Takeda (TiGenix) Recent Development
Table 90. CBR Company Detail
Table 91. CBR Business Overview
Table 92. CBR Stem Cells Product
Table 93. CBR Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 94. CBR Recent Development
Table 95. ViaCord Company Detail
Table 96. ViaCord Business Overview
Table 97. ViaCord Stem CellsProduct
Table 98. ViaCord Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 99. ViaCord Recent Development
Table 100. Esperite Company Detail
Table 101. Esperite Business Overview
Table 102. Esperite Stem CellsProduct
Table 103. Esperite Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 104. Esperite Recent Development
Table 105. LifeCell Company Detail
Table 106. LifeCell Business Overview
Table 107. LifeCell Stem CellsProduct
Table 108. LifeCell Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 109. LifeCell Recent Development
Table 110. CCBC Company Detail
Table 111. CCBC Business Overview
Table 112. CCBC Stem CellsProduct
Table 113. CCBC Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 114. CCBC Recent Development
Table 115. VCANBIO Company Detail
Table 116. VCANBIO Business Overview
Table 117. VCANBIO Stem CellsProduct
Table 118. VCANBIO Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 119. VCANBIO Recent Development
Table 120. BOYA LIFE Company Detail
Table 121. BOYA LIFE Business Overview
Table 122. BOYA LIFE Stem CellsProduct
Table 123. BOYA LIFE Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 124. BOYA LIFE Recent Development
Table 125. Beike Biotechnology Company Detail
Table 126. Beike Biotechnology Business Overview
Table 127. Beike Biotechnology Stem CellsProduct
Table 128. Beike Biotechnology Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 129. Beike Biotechnology Recent Development
Table 130. International Medical Company Detail
Table 131. International Medical Business Overview
Table 132. International Medical Stem CellsProduct
Table 133. International Medical Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 134. International Medical Recent Development
Table 135. Osiris Therapeutics Company Information
Table 136. Osiris Therapeutics Business Overview
Table 137. Osiris Therapeutics Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 138. Osiris Therapeutics Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 139. Osiris Therapeutics Recent Development
Table 140. NuVasive Company Information
Table 141. NuVasive Business Overview
Table 142. NuVasive Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 143. NuVasive Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 144. NuVasive Recent Development
Table 145. Chiesi Pharmaceuticals Company Information
Table 146. Chiesi Pharmaceuticals Business Overview
Table 147. Chiesi Pharmaceuticals Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 148. Chiesi Pharmaceuticals Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 149. Chiesi Pharmaceuticals Recent Development
Table 150. Medi-post Company Information
Table 151. Medi-post Business Overview
Table 152. Medi-post Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 153. Medi-post Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 154. Medi-post Recent Development
Table 155. JCR Pharmaceutical Company Information
Table 156. JCR Pharmaceutical Business Overview
Table 157. JCR Pharmaceutical Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 158. JCR Pharmaceutical Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 159. JCR Pharmaceutical Recent Development
Table 160. MolMed Company Information
Table 161. MolMed Business Overview
Table 162. MolMed Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 163. MolMed Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 164. MolMed Recent Development
Table 165. Pharmicell Company Information
Table 166. Pharmicell Business Overview
Table 167. Pharmicell Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 168. Pharmicell Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 169. Pharmicell Recent Development
Table 170. Anterogen Company Information
Table 171. Anterogen Business Overview
Table 172. Anterogen Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 173. Anterogen Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 174. Anterogen Recent Development
Table 175. Takeda (TiGenix) Company Information
Table 176. Takeda (TiGenix) Business Overview
Table 177. Takeda (TiGenix) Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 178. Takeda (TiGenix) Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 179. Takeda (TiGenix) Recent Development
Table 180. CBR Company Information
Table 181. CBR Business Overview
Table 182. CBR Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 183. CBR Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 184. CBR Recent Development
Table 185. ViaCord Company Information
Table 186. ViaCord Business Overview
Table 187. ViaCord Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 188. ViaCord Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 189. ViaCord Recent Development
Table 190. Esperite Company Information
Table 191. Esperite Business Overview
Table 192. Esperite Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 193. Esperite Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 194. Esperite Recent Development
Table 195. LifeCell Company Information
Table 196. LifeCell Business Overview
Table 197. LifeCell Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 198. LifeCell Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 199. LifeCell Recent Development
Table 200. CCBC Company Information
Table 201. CCBC Business Overview
Table 202. CCBC Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 203. CCBC Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 204. CCBC Recent Development
Table 205. VCANBIO Company Information
Table 206. VCANBIO Business Overview
Table 207. VCANBIO Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 208. VCANBIO Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 209. VCANBIO Recent Development
Table 210. BOYA LIFE Company Information
Table 211. BOYA LIFE Business Overview
Table 212. BOYA LIFE Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 213. BOYA LIFE Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 214. BOYA LIFE Recent Development
Table 215. Beike Biotechnology Company Information
Table 216. Beike Biotechnology Business Overview
Table 217. Beike Biotechnology Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 218. Beike Biotechnology Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 219. Beike Biotechnology Recent Development
Table 220. International Medical Company Information
Table 221. International Medical Business Overview
Table 222. International Medical Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 223. International Medical Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 224. International Medical Recent Development
Table 225. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Stem Cells Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Stem Cells Revenue Market Share by Type (2018-2023)
Table 7. Global Stem Cells Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Stem Cells Revenue Market Share by Type (2024-2029)
Table 9. Global Stem Cells Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Stem Cells Revenue Market Share by Application (2018-2023)
Table 11. Global Stem Cells Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Stem Cells Revenue Market Share by Application (2024-2029)
Table 13. Global Stem Cells Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Stem Cells Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Stem Cells Market Share by Region (2018-2023)
Table 16. Global Stem Cells Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Stem Cells Market Share by Region (2024-2029)
Table 18. Stem Cells Market Trends
Table 19. Stem Cells Market Drivers
Table 20. Stem Cells Market Challenges
Table 21. Stem Cells Market Restraints
Table 22. Global Top Stem Cells Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Stem Cells Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Stem Cells Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Stem Cells, Headquarters and Area Served
Table 26. Global Stem Cells Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Stem Cells by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Stem Cells Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Stem Cells Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Stem Cells Market Size by Country (2024-2029) & (US$ Million)
Table 45. Osiris Therapeutics Company Detail
Table 46. Osiris Therapeutics Business Overview
Table 47. Osiris Therapeutics Stem Cells Product
Table 48. Osiris Therapeutics Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 49. Osiris Therapeutics Recent Development
Table 50. NuVasive Company Detail
Table 51. NuVasive Business Overview
Table 52. NuVasive Stem Cells Product
Table 53. NuVasive Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 54. NuVasive Recent Development
Table 55. Chiesi Pharmaceuticals Company Detail
Table 56. Chiesi Pharmaceuticals Business Overview
Table 57. Chiesi Pharmaceuticals Stem Cells Product
Table 58. Chiesi Pharmaceuticals Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 59. Chiesi Pharmaceuticals Recent Development
Table 60. Medi-post Company Detail
Table 61. Medi-post Business Overview
Table 62. Medi-post Stem Cells Product
Table 63. Medi-post Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 64. Medi-post Recent Development
Table 65. JCR Pharmaceutical Company Detail
Table 66. JCR Pharmaceutical Business Overview
Table 67. JCR Pharmaceutical Stem Cells Product
Table 68. JCR Pharmaceutical Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 69. JCR Pharmaceutical Recent Development
Table 70. MolMed Company Detail
Table 71. MolMed Business Overview
Table 72. MolMed Stem Cells Product
Table 73. MolMed Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 74. MolMed Recent Development
Table 75. Pharmicell Company Detail
Table 76. Pharmicell Business Overview
Table 77. Pharmicell Stem Cells Product
Table 78. Pharmicell Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 79. Pharmicell Recent Development
Table 80. Anterogen Company Detail
Table 81. Anterogen Business Overview
Table 82. Anterogen Stem Cells Product
Table 83. Anterogen Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 84. Anterogen Recent Development
Table 85. Takeda (TiGenix) Company Detail
Table 86. Takeda (TiGenix) Business Overview
Table 87. Takeda (TiGenix) Stem Cells Product
Table 88. Takeda (TiGenix) Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 89. Takeda (TiGenix) Recent Development
Table 90. CBR Company Detail
Table 91. CBR Business Overview
Table 92. CBR Stem Cells Product
Table 93. CBR Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 94. CBR Recent Development
Table 95. ViaCord Company Detail
Table 96. ViaCord Business Overview
Table 97. ViaCord Stem CellsProduct
Table 98. ViaCord Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 99. ViaCord Recent Development
Table 100. Esperite Company Detail
Table 101. Esperite Business Overview
Table 102. Esperite Stem CellsProduct
Table 103. Esperite Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 104. Esperite Recent Development
Table 105. LifeCell Company Detail
Table 106. LifeCell Business Overview
Table 107. LifeCell Stem CellsProduct
Table 108. LifeCell Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 109. LifeCell Recent Development
Table 110. CCBC Company Detail
Table 111. CCBC Business Overview
Table 112. CCBC Stem CellsProduct
Table 113. CCBC Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 114. CCBC Recent Development
Table 115. VCANBIO Company Detail
Table 116. VCANBIO Business Overview
Table 117. VCANBIO Stem CellsProduct
Table 118. VCANBIO Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 119. VCANBIO Recent Development
Table 120. BOYA LIFE Company Detail
Table 121. BOYA LIFE Business Overview
Table 122. BOYA LIFE Stem CellsProduct
Table 123. BOYA LIFE Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 124. BOYA LIFE Recent Development
Table 125. Beike Biotechnology Company Detail
Table 126. Beike Biotechnology Business Overview
Table 127. Beike Biotechnology Stem CellsProduct
Table 128. Beike Biotechnology Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 129. Beike Biotechnology Recent Development
Table 130. International Medical Company Detail
Table 131. International Medical Business Overview
Table 132. International Medical Stem CellsProduct
Table 133. International Medical Revenue in Stem Cells Business (2017-2022) & (US$ Million)
Table 134. International Medical Recent Development
Table 135. Osiris Therapeutics Company Information
Table 136. Osiris Therapeutics Business Overview
Table 137. Osiris Therapeutics Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 138. Osiris Therapeutics Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 139. Osiris Therapeutics Recent Development
Table 140. NuVasive Company Information
Table 141. NuVasive Business Overview
Table 142. NuVasive Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 143. NuVasive Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 144. NuVasive Recent Development
Table 145. Chiesi Pharmaceuticals Company Information
Table 146. Chiesi Pharmaceuticals Business Overview
Table 147. Chiesi Pharmaceuticals Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 148. Chiesi Pharmaceuticals Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 149. Chiesi Pharmaceuticals Recent Development
Table 150. Medi-post Company Information
Table 151. Medi-post Business Overview
Table 152. Medi-post Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 153. Medi-post Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 154. Medi-post Recent Development
Table 155. JCR Pharmaceutical Company Information
Table 156. JCR Pharmaceutical Business Overview
Table 157. JCR Pharmaceutical Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 158. JCR Pharmaceutical Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 159. JCR Pharmaceutical Recent Development
Table 160. MolMed Company Information
Table 161. MolMed Business Overview
Table 162. MolMed Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 163. MolMed Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 164. MolMed Recent Development
Table 165. Pharmicell Company Information
Table 166. Pharmicell Business Overview
Table 167. Pharmicell Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 168. Pharmicell Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 169. Pharmicell Recent Development
Table 170. Anterogen Company Information
Table 171. Anterogen Business Overview
Table 172. Anterogen Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 173. Anterogen Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 174. Anterogen Recent Development
Table 175. Takeda (TiGenix) Company Information
Table 176. Takeda (TiGenix) Business Overview
Table 177. Takeda (TiGenix) Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 178. Takeda (TiGenix) Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 179. Takeda (TiGenix) Recent Development
Table 180. CBR Company Information
Table 181. CBR Business Overview
Table 182. CBR Stem Cells Revenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 183. CBR Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 184. CBR Recent Development
Table 185. ViaCord Company Information
Table 186. ViaCord Business Overview
Table 187. ViaCord Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 188. ViaCord Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 189. ViaCord Recent Development
Table 190. Esperite Company Information
Table 191. Esperite Business Overview
Table 192. Esperite Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 193. Esperite Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 194. Esperite Recent Development
Table 195. LifeCell Company Information
Table 196. LifeCell Business Overview
Table 197. LifeCell Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 198. LifeCell Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 199. LifeCell Recent Development
Table 200. CCBC Company Information
Table 201. CCBC Business Overview
Table 202. CCBC Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 203. CCBC Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 204. CCBC Recent Development
Table 205. VCANBIO Company Information
Table 206. VCANBIO Business Overview
Table 207. VCANBIO Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 208. VCANBIO Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 209. VCANBIO Recent Development
Table 210. BOYA LIFE Company Information
Table 211. BOYA LIFE Business Overview
Table 212. BOYA LIFE Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 213. BOYA LIFE Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 214. BOYA LIFE Recent Development
Table 215. Beike Biotechnology Company Information
Table 216. Beike Biotechnology Business Overview
Table 217. Beike Biotechnology Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 218. Beike Biotechnology Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 219. Beike Biotechnology Recent Development
Table 220. International Medical Company Information
Table 221. International Medical Business Overview
Table 222. International Medical Stem CellsRevenue in Stem Cells Business (2018-2023) & (US$ Million)
Table 223. International Medical Revenue in Stem Cells Business (2018-2023) & (US$ Million) Portfolio
Table 224. International Medical Recent Development
Table 225. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Stem Cells Product Picture
Figure 5. Global Stem Cells Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Stem Cells Market Share by Type: 2022 VS 2029
Figure 7. Stem Cell Storage Product Picture
Figure 8. Stem Cell Pharmaceutical and Treatment Product Picture
Figure 9. Global Stem Cells Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Stem Cells Market Share by Application: 2022 VS 2029
Figure 11. Diseases of the Central Nervous System Product Picture
Figure 12. Cardiovascular Disease Product Picture
Figure 13. Diabetes Product Picture
Figure 14. Cancer Product Picture
Figure 15. Genetic Diseases Product Picture
Figure 16. Autoimmune Disease Product Picture
Figure 17. Bone and Cartilage Repair Product Picture
Figure 18. Other Product Picture
Figure 19. Global Stem Cells Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Stem Cells Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Stem Cells Market Share by Region: 2022 VS 2029
Figure 22. Global Stem Cells Market Share by Players in 2022
Figure 23. Global Stem Cells Players, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Stem Cells Players Market Share by Revenue in 2022
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. North America Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. North America Stem Cells Market Share by Country (2018-2029)
Figure 28. United States Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Stem Cells Market Share by Country (2018-2029)
Figure 32. Germany Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Stem Cells Market Share by Country (2018-2029)
Figure 40. China Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Japan Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Latin America Stem Cells Market Share by Country (2018-2029)
Figure 48. Mexico Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Brazil Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Stem Cells Market Share by Country (2018-2029)
Figure 52. Turkey Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. UAE Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Osiris Therapeutics Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 56. NuVasive Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 57. Chiesi Pharmaceuticals Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 58. Medi-post Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 59. JCR Pharmaceutical Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 60. MolMed Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 61. Pharmicell Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 62. Anterogen Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 63. Takeda (TiGenix) Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 64. CBR Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 65. ViaCord Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 66. Esperite Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 67. LifeCell Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 68. CCBC Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 69. VCANBIO Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 70. BOYA LIFE Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 71. Beike Biotechnology Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 72. International Medical Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Stem Cells Product Picture
Figure 5. Global Stem Cells Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Stem Cells Market Share by Type: 2022 VS 2029
Figure 7. Stem Cell Storage Product Picture
Figure 8. Stem Cell Pharmaceutical and Treatment Product Picture
Figure 9. Global Stem Cells Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Stem Cells Market Share by Application: 2022 VS 2029
Figure 11. Diseases of the Central Nervous System Product Picture
Figure 12. Cardiovascular Disease Product Picture
Figure 13. Diabetes Product Picture
Figure 14. Cancer Product Picture
Figure 15. Genetic Diseases Product Picture
Figure 16. Autoimmune Disease Product Picture
Figure 17. Bone and Cartilage Repair Product Picture
Figure 18. Other Product Picture
Figure 19. Global Stem Cells Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 20. Global Stem Cells Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 21. Global Stem Cells Market Share by Region: 2022 VS 2029
Figure 22. Global Stem Cells Market Share by Players in 2022
Figure 23. Global Stem Cells Players, Date of Enter into This Industry
Figure 24. Global Top 5 and 10 Stem Cells Players Market Share by Revenue in 2022
Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. North America Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. North America Stem Cells Market Share by Country (2018-2029)
Figure 28. United States Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Canada Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Europe Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Europe Stem Cells Market Share by Country (2018-2029)
Figure 32. Germany Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Asia-Pacific Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Stem Cells Market Share by Country (2018-2029)
Figure 40. China Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Japan Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Latin America Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Latin America Stem Cells Market Share by Country (2018-2029)
Figure 48. Mexico Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Brazil Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa Stem Cells Market Share by Country (2018-2029)
Figure 52. Turkey Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. UAE Stem Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Osiris Therapeutics Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 56. NuVasive Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 57. Chiesi Pharmaceuticals Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 58. Medi-post Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 59. JCR Pharmaceutical Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 60. MolMed Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 61. Pharmicell Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 62. Anterogen Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 63. Takeda (TiGenix) Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 64. CBR Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 65. ViaCord Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 66. Esperite Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 67. LifeCell Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 68. CCBC Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 69. VCANBIO Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 70. BOYA LIFE Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 71. Beike Biotechnology Revenue Growth Rate in Stem Cells Business (2018-2023)
Figure 72. International Medical Revenue Growth Rate in Stem Cells Business (2018-2023)
